New announced research finds Epiontis ID™ technology can advance newborn screening as well as treatment of HIV patients in low-resource countries. (more…)
We are excited to announce that Precision Value & Health, a business unit of Precision Medicine Group, has been ranked #6 in MM&M magazine’s Agency Top 100 list! With a 10.6% increase in revenue from the previous year, they are continuing to add talent and services–partnering with pharmaceutical and life sciences companies to ensure patient access to life-changing therapies. (more…)
Precision is pleased to announce that Dan Renick has been named as one of PM360 Magazine’s annual ELITE Award winners. Congratulations, Dan! (more…)
In an interview with KNect365, Precision Oncology’s Dr. Tandy Tipps, VP, Oncology Site Network, tells you how to match the right sites to the right trials and enable the opportunities of precision oncology trials. (more…)
In an article in Pharmaceutical Commerce, Precision’s Dominic Galante and Maureen Hennessey stress the importance of patient support services among pharma companies, payers, and providers. (more…)
Register today for our upcoming free live webinar Defend Your Value: Syncing Evidence and Access Strategies to Prepare for US Value Assessments on Wednesday, April 18, at 1:00 pm ET. (more…)
Precision’s Jason Shafrin comments in PMLive on the importance of real-world evidence and the benefits of electronic medical records in generating evidence. (more…)
We are pleased to announce that Med Ad News has named Precision Value & Health as a finalist for the 2018 Vision Award, to be presented as part of their annual Manny Awards ceremony on April 19 in New York City. (more…)
A new attention-grabbing PHE study, commissioned by the Alzheimer’s Association, investigates the potential savings of obtaining an earlier diagnosis. (more…)